RETRACTED: The Significance of PAX8-PPAR<i>γ</i> Expression in Thyroid Cancer and the Application of a PAX8-PPAR<i>γ</i>-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer

<div>The lethal effect of SW579 cells in different terms. (a) Control; (b–e) NPs-PAX8-PPAR<i>γ</i>5 pmol/mL, 10 pmol/mL, 15 pmol/mL, and 20 pmol/mL; (f) DOX 0.5 umol/mL.</div>

Contrast Media & Molecular Imaging

fig10

Figure 10

Figure 10: RETRACTED: The Significance of PAX8-PPAR<i>γ</i> Expression in Thyroid Cancer and the Application of a PAX8-PPAR<i>γ</i>-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer 

Figure 10 | RETRACTED: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer 